Skip to main content
Mobile dropdown close
More coming soon
Top Tips: Explore these additional resources
1 - 10 of 13 Displaying Results
To Aggregate or Not: 5 Deciding Factors
Here are 5 questions to ask yourself when creating a strategy for serial number aggregation that will set you up for long-term success.
5 Reasons Why Paper Creates Risk for Dispensers
If you haven’t started receiving transaction documentation (T3) in electronic format, your paperwork could be throwing you out of compliance.
Countdown to November 27: Six Milestones That Should Be Behind You
6 milestones your pharma company should have already passed on the road to DSCSA serialization readiness for the November 2017 deadline.
Preparing for Russia Compliance: 6 Critical Considerations
Companies that sell product into Russia need to focus on six critical considerations, and understand how Russia challenges differ from those of FMD…
Russia Update: 12 Nosologies Deadlines and Crypto Coding Confirmed
Read about two official Russian compliance declarations, including 12 Nosologies deadlines and crypto coding.
Russia Compliance and Crypto Coding: Top 8 Questions Answered
Read the answers to 8 Russia compliance and cryptographic coding questions.
Are Your Products China Ready? Three Key Decisions for Multinational Pharma Companies
China's drug administration law and serialization framework for medicines could affect your China product packaging strategy. Learn how today.
Achieve Operational Excellence in Russia with Proactive Supply Chain Monitoring
Russia compliance whitepaper: Learn how Serialized Product Intelligence from TraceLink can help you streamline serialized operations in Russia.
Proactive Monitoring for Rapid Reporting and Decision Making with SPI
Learn how companies can leverage serialization data to track and forecast quarterly production and take proactive action.
Global Visibility into Product Commissioning and Aggregation with SPI
Learn how companies can use Serialized Product Intelligence to track products across multiple geographies and compliance mandates.